Valeant Pharmaceuticals has released a merger & acquisition news to acquire all of the outstanding common stock of Solta Medical for $2.92 per share in cash. Read the full story
Valeant Pharmaceuticals has released a merger & acquisition news to acquire all of the outstanding common stock of Solta Medical for $2.92 per share in cash. Read the full story
In M&A news, Simcere Pharmaceutical Group has entered into a merger agreement for around $495 million. Read the full story
Kinetic Concepts announces merger and acquisition agreement of UK-based Systagenix, an established provider of advanced wound care products, for a purchase price of $485 million Read the full story
This year has seen a lower frequency in pharma merger and acquisition (M&A) activity with 255 deals announced in the first six months of 2012 compared to 199 deals this year (2013) according to Current Agreements Read the full story